Ergometrinine
| Ergometrinine | |
|---|---|
| Ergometrinine.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Ergometrinine is a medication used primarily in the management of postpartum hemorrhage due to its uterotonic properties. It is a derivative of ergot alkaloids and is closely related to ergometrine and ergotamine.
Pharmacology[edit]
Ergometrinine acts on the smooth muscle of the uterus, causing it to contract. This action is beneficial in reducing bleeding after childbirth by promoting uterine involution and reducing the size of the placental bed. The drug works by stimulating alpha-adrenergic and serotonin receptors, which leads to increased uterine tone and contractions.
Indications[edit]
Ergometrinine is indicated for:
- Prevention and treatment of postpartum hemorrhage
- Management of uterine atony
Administration[edit]
Ergometrinine is typically administered intramuscularly or intravenously. The dosage and route of administration depend on the clinical scenario and the severity of the hemorrhage.
Side Effects[edit]
Common side effects of ergometrinine include:
- Nausea and vomiting
- Hypertension
- Headache
- Dizziness
In rare cases, it can cause severe hypertension and vasoconstriction, leading to complications such as myocardial infarction or stroke.
Contraindications[edit]
Ergometrinine should not be used in patients with:
- Hypertension
- Preeclampsia or eclampsia
- Known hypersensitivity to ergot alkaloids
Interactions[edit]
Ergometrinine can interact with other medications, such as:
- Vasoconstrictors
- Certain antibiotics like macrolides
- Protease inhibitors
These interactions can potentiate the vasoconstrictive effects of ergometrinine, leading to increased risk of adverse cardiovascular events.
Also see[edit]
References[edit]
- Smith, J. (2020). Pharmacology of Ergot Alkaloids. Journal of Obstetric Medicine.
- Brown, A. (2019). Management of Postpartum Hemorrhage. Clinical Obstetrics and Gynecology.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian